• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.

作者信息

Koike Yuta, Fujiki Yumi, Higuchi Maho, Fukuchi Reika, Kuwatsuka Sayaka, Murota Hiroyuki

机构信息

Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

出版信息

JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb.

DOI:10.1016/j.jdcr.2018.11.016
PMID:30733983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6355324/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9387/6355324/a6a7bac9f520/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9387/6355324/a6a7bac9f520/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9387/6355324/a6a7bac9f520/gr1.jpg

相似文献

1
An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.一种白细胞介素-17抑制剂成功治疗了一名患有乙型肝炎病毒感染和终末期肾病且正在接受血液透析的复杂银屑病和银屑病关节炎患者。
JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb.
2
Occult hepatitis B virus infection of hemodialysis patients: a cross-sectional study in a hepatitis B virus-endemic region.血液透析患者的隐匿性乙型肝炎病毒感染：一项在乙型肝炎病毒流行地区的横断面研究。
Hemodial Int. 2015 Jan;19(1):66-71. doi: 10.1111/hdi.12214. Epub 2014 Sep 5.
3
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.司库奇尤单抗用于治疗中度至重度斑块状银屑病和银屑病关节炎的成人患者。
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1423-1433. doi: 10.1080/17512433.2016.1242409. Epub 2016 Oct 11.
4
Successful Treatment with Bimekizumab of a Psoriatic Patient Undergoing Hemodialysis: A Case Report and Review of the Literature.用比美吉珠单抗成功治疗一名正在接受血液透析的银屑病患者：病例报告及文献综述
J Clin Med. 2024 Apr 12;13(8):2250. doi: 10.3390/jcm13082250.
5
Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.在台湾，使用抗肿瘤坏死因子-α 疗法治疗乙型肝炎病毒携带者的银屑病或银屑病关节炎：一项病例系列研究。
J Dermatol. 2012 Mar;39(3):269-73. doi: 10.1111/j.1346-8138.2011.01434.x. Epub 2011 Nov 14.
6
Ixekizumab for the treatment of psoriasis: an update on new data since first approval.依奇珠单抗治疗银屑病：首次批准以来新数据的更新。
Expert Rev Clin Immunol. 2019 Feb;15(2):111-121. doi: 10.1080/1744666X.2019.1559730. Epub 2018 Dec 27.
7
[Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].[采用血清学和分子方法对血液透析患者进行乙型和丙型肝炎病毒感染调查]
Mikrobiyol Bul. 2014 Jan;48(1):143-50.
8
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.接受生物制剂治疗的银屑病患者乙肝病毒感染再激活风险：来自BIOBADADERM数据库20例病例的回顾性分析
Actas Dermosifiliogr. 2015 Jul-Aug;106(6):477-82. doi: 10.1016/j.ad.2015.01.010. Epub 2015 Mar 13.
9
Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection.日本血液透析患者中的乙型肝炎病毒感染：患病率、发病率及隐匿性乙型肝炎病毒感染
Hepatol Res. 2015 Dec;45(12):1211-9. doi: 10.1111/hepr.12492. Epub 2015 Feb 19.
10
Hepatitis B and C virus infection in the hemodialysis population from three romanian regions.罗马尼亚三个地区血液透析人群中的乙型和丙型肝炎病毒感染
Nephron. 2015;129(3):202-8. doi: 10.1159/000371450. Epub 2015 Mar 4.

引用本文的文献

1
Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis.司库奇尤单抗成功治疗一名接受血液透析的银屑病患者。
Psoriasis (Auckl). 2025 Jul 23;15:321-325. doi: 10.2147/PTT.S536639. eCollection 2025.
2
Successful Treatment with Bimekizumab of a Psoriatic Patient Undergoing Hemodialysis: A Case Report and Review of the Literature.用比美吉珠单抗成功治疗一名正在接受血液透析的银屑病患者：病例报告及文献综述
J Clin Med. 2024 Apr 12;13(8):2250. doi: 10.3390/jcm13082250.
3
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection.

本文引用的文献

1
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.S3 寻常型银屑病治疗指南更新版——短版 1 部分：系统治疗。
J Dtsch Dermatol Ges. 2018 May;16(5):645-669. doi: 10.1111/ddg.13516.
2
Safety of secukinumab in hepatitis B virus.
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e120-e121. doi: 10.1111/jdv.14608. Epub 2017 Oct 16.
3
Efficacy of biologics in psoriasis patients under hemodialysis.生物制剂在血液透析的银屑病患者中的疗效。
替拉珠单抗治疗慢性乙型肝炎病毒感染患者的疗效和安全性
Clin Cosmet Investig Dermatol. 2023 Feb 5;16:369-373. doi: 10.2147/CCID.S403294. eCollection 2023.
4
Effectiveness of Dialysis in Psoriasis: A Short Review.透析治疗银屑病的有效性：简短综述
Cureus. 2022 Oct 8;14(10):e30061. doi: 10.7759/cureus.30061. eCollection 2022 Oct.
5
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.银屑病的新型治疗方法与传染病风险
Biomedicines. 2022 Jan 21;10(2):228. doi: 10.3390/biomedicines10020228.
6
Ixekizumab May Improve Renal Function in Psoriasis.司库奇尤单抗可能改善银屑病患者的肾功能。
Healthcare (Basel). 2021 May 7;9(5):543. doi: 10.3390/healthcare9050543.
7
Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.自身免疫性疾病患者在接受非肿瘤坏死因子靶向生物制剂治疗时乙型肝炎病毒再激活的风险。
World J Gastroenterol. 2021 May 21;27(19):2312-2324. doi: 10.3748/wjg.v27.i19.2312.
8
The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection.优特克单抗和古塞库单抗在一名患有活动性乙型肝炎感染的儿童银屑病患者中的应用。
JAAD Case Rep. 2020 Dec 14;8:37-39. doi: 10.1016/j.jdcr.2020.12.006. eCollection 2021 Feb.
9
Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors.银屑病患者的皮肤微生物组在接受 TNF 和 IL-17 抑制剂治疗期间得以保留。
Int J Mol Sci. 2020 May 29;21(11):3892. doi: 10.3390/ijms21113892.
10
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.风湿性疾病中乙型肝炎病毒感染的再激活：风险及管理考量
Ther Adv Musculoskelet Dis. 2020 Mar 16;12:1759720X20912646. doi: 10.1177/1759720X20912646. eCollection 2020.
Eur J Dermatol. 2017 Oct 1;27(5):531-533. doi: 10.1684/ejd.2017.3064.
4
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.英国皮肤科医师协会2017年银屑病生物治疗指南。
Br J Dermatol. 2017 Sep;177(3):628-636. doi: 10.1111/bjd.15665.
5
Psoriasis vulgaris in a hepatitis B virus carrier successfully treated with secukinumab and entecavir combination therapy.
Eur J Dermatol. 2017 Apr 1;27(2):185-186. doi: 10.1684/ejd.2016.2939.
6
Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure.阿达木单抗成功治疗一名因肾衰竭接受血液透析的寻常型银屑病患者：病例报告及既往关于生物制剂治疗因肾衰竭接受血液透析的银屑病患者报告的综述
J Dermatol. 2015 Jul;42(7):727-30. doi: 10.1111/1346-8138.12901. Epub 2015 Apr 28.
7
IL-17A in hepatitis B infection: friend or foe?白细胞介素-17A 在乙型肝炎感染中的作用：是敌是友？
Arch Virol. 2014 Aug;159(8):1883-8. doi: 10.1007/s00705-014-2002-x. Epub 2014 Feb 18.
8
Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy.预防接受免疫抑制治疗或化疗的患者乙型肝炎病毒再激活。
Hepatol Res. 2012 Jul;42(7):627-36. doi: 10.1111/j.1872-034X.2012.00998.x.